No plans to delist Ranbaxy, says chairman

Normal 0 false false false MicrosoftInternetExplorer4 st1\:{behavior:url(#ieooui) } / Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;} Daiichi Sankyo of Japan has a 63.67 per cent stake in the Indian drug manufacturer while its public holding is about 16 per cent.

PTI

New Delhi,
Updated Apr 26, 2012 11:08 AM IST

No plans to delist Ranbaxy, says chairman

Ranbaxy Laboratories has said the company has no plans to delist from Indian bourses and it will remain a listed company.

"We have no intention to delist. Ranbaxy is an Indian diamond and will remain so," Ranbaxy Chairman Tsutomu Une told reporters when asked if the company had any plans to delist.

Daiichi Sankyo of Japan has a 63.67 per cent stake in the Indian drug manufacturer after it acquired the company in 2008 for Rs 22,000 crore from promoters led by Malvinder Singh.

FIIs hold 9.56 per cent of the company's share while domestic institutions have a 10.91 per cent stake, leaving a public holding of 15.86 per cent.

The company is listed on the National and Bombay Stock Exchanges.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

Published on: Apr 26, 2012 11:02 AM IST

No plans to delist Ranbaxy, says chairman

Related Articles

TOP STORIES

TOP VIDEOS